Correspondence 0001193125-24-000732 from BrightSpring Health Services, Inc. (BTSG)
BrightSpring Health Services, Inc.
Date: Jan. 2, 2024 · CIK: 0001865782 · Accession: 0001193125-24-000732
AI Filing Summary & Sentiment
File numbers found in text: 333-260334
Referenced dates: January 2, 2024
Letter
SIMPSON THACHER & BARTLETT LLP
425 LEXINGTON AVENUE
NEW YORK, NY 10017-3954
(212) 455-2000
FACSIMILE (212) 455-2502
DIRECT DIAL NUMBER
(212) 455-2948
E-MAIL ADDRESS JKAUFMAN@STBLAW.COM
January 2, 2024
VIA EDGAR TRANSMISSION
Re: BrightSpring Health Services, Inc.
Amendment No. 3 to Draft Registration Statement on Form S-1
Submitted December 18, 2023
CIK No. 0001865782
Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington D.C. 20549-3561
Ladies and Gentlemen:
On behalf of BrightSpring Health Services, Inc. (the “Company”), we hereby transmit via EDGAR for filing with the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1 (the “Registration Statement”). The Company has prepared the Registration Statement (i) in response to the Staff’s comments in its letter, dated January 2, 2024 (the “Comment Letter”), (ii) to reflect that is the Registration Statement is filed rather than confidentially submitted, and (iii) to reflect certain other changes. In addition, the Company has filed certain exhibits with the Registration Statement and advises the Staff that it will file any remaining required exhibits in one or more future pre-effective amendments.
The filing fee in the amount of $10,981 was deposited by wire transfer of same-day funds to the Commission’s account at U.S. Bank in St. Louis, Missouri on December 27, 2023, as required by Rule 111 of the Securities Act of 1933, as amended (the “Securities Act”). The Company previously publicly filed a registration statement on Form S-1 with the Commission initially on October 18, 2021 (File No. 333-260334), including all exhibits submitted therewith and all amendments thereto (collectively, the “Prior Registration Statement”), also relating to a proposed offering of its common stock and a concurrent offering of its tangible equity units. On November 23, 2022, pursuant to Rule 477(a) promulgated under the Securities Act, the Company made a request to the Commission to withdraw the Prior Registration Statement, which had not been declared effective, effective as of the date thereof or as soon as practicable thereafter. The Company further requested that, in accordance with Rule 457(p) promulgated
Securities and Exchange Commission
January 2, 2024
under the Securities Act, all fees paid to the Commission in connection with the filing of the Prior Registration Statement be credited for the Company’s account to be offset against the filing fee for any future registration statement of the Company, including the Registration Statement.
In addition, we are providing the following responses to the Staff’s Comment Letter. To assist your review, we have retyped the text of the Staff’s comments in italics below. Page references in the text of this letter correspond to the pages of the Registration Statement. Unless otherwise defined below, terms defined in the Registration Statement and used below shall have the meanings given to them in the Registration Statement. The responses and information described below are based upon information provided to us by the Company.
Securities and Exchange Commission
January 2, 2024
Recent Developments
Preliminary, Unaudited Estimated Financial and Other Data as of and for the Year Ended December 31, 2023, page 22
1. We refer to your statements that “[o]ur actual results may be materially different from our estimates, which should not be regarded as a representation by us, our management or the underwriters as to our actual results as of and for the year ended December 31, 2023” and that investors “should not place undue reliance on these estimates.” If you choose to disclose preliminary estimates, you should be able to assert that the actual results are not expected to differ materially from those reflected in the preliminary estimates. Further, it is not appropriate to directly or indirectly disclaim liability for statements in your registration statement. Accordingly, please delete these statements or revise to specifically state that you take liability for them.
The Company has revised its disclosure on page 22 to remove these statements in their entirety.
Legal Proceedings, page 175
2. We note your disclosure that the estimated financial impact of the settlement of the Silver matter is $115.0 million, which you accrued in the nine months ended September 30, 2023. If known, please provide a general estimate of when you expect a final settlement agreement could be approved and cash payment of the settlement amount made. Please note the anticipated source of funds to be used to pay the settlement amount, including any anticipated increase in net debt and any related impacts such as a decrease in available borrowing capacity.
The Company has revised its disclosure on page 175 in response to the Staff’s comment.
***
Please do not hesitate to call me at (212) 455-2948 with any questions or further comments regarding this filing or if you wish to discuss any of the above responses.
Very truly yours,
/s/ Joseph H. Kaufman
Show Raw Text
CORRESP 1 filename1.htm CORRESP SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, NY 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER (212) 455-2948 E-MAIL ADDRESS JKAUFMAN@STBLAW.COM January 2, 2024 VIA EDGAR TRANSMISSION Re: BrightSpring Health Services, Inc. Amendment No. 3 to Draft Registration Statement on Form S-1 Submitted December 18, 2023 CIK No. 0001865782 Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington D.C. 20549-3561 Ladies and Gentlemen: On behalf of BrightSpring Health Services, Inc. (the “Company”), we hereby transmit via EDGAR for filing with the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1 (the “Registration Statement”). The Company has prepared the Registration Statement (i) in response to the Staff’s comments in its letter, dated January 2, 2024 (the “Comment Letter”), (ii) to reflect that is the Registration Statement is filed rather than confidentially submitted, and (iii) to reflect certain other changes. In addition, the Company has filed certain exhibits with the Registration Statement and advises the Staff that it will file any remaining required exhibits in one or more future pre-effective amendments. The filing fee in the amount of $10,981 was deposited by wire transfer of same-day funds to the Commission’s account at U.S. Bank in St. Louis, Missouri on December 27, 2023, as required by Rule 111 of the Securities Act of 1933, as amended (the “Securities Act”). The Company previously publicly filed a registration statement on Form S-1 with the Commission initially on October 18, 2021 (File No. 333-260334), including all exhibits submitted therewith and all amendments thereto (collectively, the “Prior Registration Statement”), also relating to a proposed offering of its common stock and a concurrent offering of its tangible equity units. On November 23, 2022, pursuant to Rule 477(a) promulgated under the Securities Act, the Company made a request to the Commission to withdraw the Prior Registration Statement, which had not been declared effective, effective as of the date thereof or as soon as practicable thereafter. The Company further requested that, in accordance with Rule 457(p) promulgated Securities and Exchange Commission January 2, 2024 under the Securities Act, all fees paid to the Commission in connection with the filing of the Prior Registration Statement be credited for the Company’s account to be offset against the filing fee for any future registration statement of the Company, including the Registration Statement. In addition, we are providing the following responses to the Staff’s Comment Letter. To assist your review, we have retyped the text of the Staff’s comments in italics below. Page references in the text of this letter correspond to the pages of the Registration Statement. Unless otherwise defined below, terms defined in the Registration Statement and used below shall have the meanings given to them in the Registration Statement. The responses and information described below are based upon information provided to us by the Company. Securities and Exchange Commission January 2, 2024 Recent Developments Preliminary, Unaudited Estimated Financial and Other Data as of and for the Year Ended December 31, 2023, page 22 1. We refer to your statements that “[o]ur actual results may be materially different from our estimates, which should not be regarded as a representation by us, our management or the underwriters as to our actual results as of and for the year ended December 31, 2023” and that investors “should not place undue reliance on these estimates.” If you choose to disclose preliminary estimates, you should be able to assert that the actual results are not expected to differ materially from those reflected in the preliminary estimates. Further, it is not appropriate to directly or indirectly disclaim liability for statements in your registration statement. Accordingly, please delete these statements or revise to specifically state that you take liability for them. The Company has revised its disclosure on page 22 to remove these statements in their entirety. Legal Proceedings, page 175 2. We note your disclosure that the estimated financial impact of the settlement of the Silver matter is $115.0 million, which you accrued in the nine months ended September 30, 2023. If known, please provide a general estimate of when you expect a final settlement agreement could be approved and cash payment of the settlement amount made. Please note the anticipated source of funds to be used to pay the settlement amount, including any anticipated increase in net debt and any related impacts such as a decrease in available borrowing capacity. The Company has revised its disclosure on page 175 in response to the Staff’s comment. *** Please do not hesitate to call me at (212) 455-2948 with any questions or further comments regarding this filing or if you wish to discuss any of the above responses. Very truly yours, /s/ Joseph H. Kaufman Joseph H. Kaufman cc: Securities and Exchange Commission Conlon Danberg Margaret Sawicki Kristin Lochhead Jeanne Baker Securities and Exchange Commission January 2, 2024 BrightSpring Health Services, Inc. Jon Rousseau Simpson Thacher & Bartlett LLP Sunny Cheong Latham & Watkins LLP Marc Jaffe Ian Schuman